Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Resveratol I Pediatric and Adolescence With Type 1 Diabetic Nephropathy: A Six Months Preliminary Exploratory Trial

NCT07332819 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07332819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07332819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Resveratol I Pediatric and Adolescence With Type 1 Diabetic Nephropathy: A Six Months Preliminary Exploratory Trial
Lead sponsor
Ain Shams University
Phase
Phase 2/3
Overall status
Completed
Start date
July 21, 2024
Completion date
August 22, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetic nephropathy